Lymphocytes upregulate signal sequence-encoding proopiomelanocortin mRNA and beta-endorphin during painful inflammation in vivo

Journal of Neuroimmunology

Volumn 183, Issue 1-2, 2007, Pages 133-145

  Sitte, Nicolle ^a   Busch, Melanie ^a   Mousa, Shaaban A ^a   Labuz, Dominika ^a   Rittner, Heike ^a   Gore, Carmen ^a   Krause, Hans ^a   Stein, Christoph ^a   Schäfer, Michael ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Complete Freund's Adjuvant; Immune system; Neuro immune interaction; Opioid peptides; Pain

Indexed keywords

BETA ENDORPHIN; MESSENGER RNA; POLYPEPTIDE; PROOPIOMELANOCORTIN; SECRETORY PROTEIN; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; IMMUNOCOMPETENT CELL; IN VIVO STUDY; INFLAMMATION; LYMPH NODE; LYMPHOCYTE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PAIN; POLYMERASE CHAIN REACTION; POPLITEAL VEIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SECRETION; SERODIAGNOSIS; UPREGULATION;

ANIMALS; BETA-ENDORPHIN; FLOW CYTOMETRY; FREUND'S ADJUVANT; GENE EXPRESSION REGULATION; INFLAMMATION; LYMPHOCYTES; MALE; PAIN; PRO-OPIOMELANOCORTIN; PROTEIN SORTING SIGNALS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

EID: 33846839488     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.11.033     Document Type: Article

References (49)

1. Binder W., Machelska H., Mousa S., Schmitt T., Riviere P.J., Junien J.L., Stein C., and Schafer M. Analgesic and antiinflammatory effects of two novel kappa-opioid peptides. Anesthesiology 94 (2001) 1034-1044
2. Binder W., Mousa S.A., Sitte N., Kaiser M., Stein C., and Schafer M. Sympathetic activation triggers endogenous opioid release and analgesia within peripheral inflamed tissue. J. Eur. Neurosci. 20 (2004) 92-100
3. Buzzetti R., McLoughlin L., Lavender P.M., Clark A.J., and Rees L.H. Expression of pro-opiomelanocortin gene and quantification of adrenocorticotropic hormone-like immunoreactivity in human normal peripheral mononuclear cells and lymphoid and myeloid malignancies. J. Clin. Invest. 83 (1989) 733-737
4. Cabot P.J., Carter L., Gaiddon C., Zhang Q., Schafer M., Loeffler J.P., and Stein C. Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats. J. Clin. Invest. 100 (1997) 142-148
5. Chadzinska M., Starowicz K., Scislowska-Czarnecka A., Bilecki W., Pierzchala-Koziec K., Przewlocki R., Przewlocka B., and Plytycz B. Morphine-induced changes in the activity of proopiomelanocortin and prodynorphin systems in zymosan-induced peritonitis in mice. Immunol. Lett. 101 (2005) 185-192
6. Cho H., Lasco T.M., Allen S.S., Yoshimura T., and McMurray D.N. Recombinant guinea pig tumor necrosis factor alpha stimulates the expression of interleukin-12 and the inhibition of Mycobacterium tuberculosis growth in macrophages. Infect. Immun. 73 (2005) 1367-1376
7. Clark A.J., Lavender P.M., Coates P., Johnson M.R., and Rees L.H. In vitro and in vivo analysis of the processing and fate of the peptide products of the short proopiomelanocortin mRNA. Mol. Endocrinol. 4 (1990) 1737-1743
8. de Longueville F., Evrard S., and Heim A. Gene expression profiling of PB and PCN. Correlation between data from DualChip rat hepato and real-time PCR. Eppendorf Application vol. 62 (2003)
9. DeBold C.R., Menefee J.K., Nicholson W.E., and Orth D.N. Proopiomelanocortin gene is expressed in many normal human tissues and in tumors not associated with ectopic adrenocorticotropin syndrome. Mol. Endocrinol. 2 (1988) 862-870
10. Drouin J., Chamberland M., Charron J., Jeannotte L., and Nemer M. Structure of the rat pro-opiomelanocortin (POMC) gene. FEBS Lett. 193 (1985) 54-58
11. Heijnen C.J., Kavelaars A., and Ballieux R.E. Beta-endorphin: cytokine and neuropeptide. Immunol. Rev. 119 (1991) 41-63
12. Hermanussen S., Do M., and Cabot P.J. Reduction of beta-endorphin-containing immune cells in inflamed paw tissue corresponds with a reduction in immune-derived antinociception: reversible by donor activated lymphocytes. Anesth. Analg. 98 (2004) 723-729
13. Jeannotte L., Burbach J.P.H., and Drouin J. Unusual proopiomelanocortin ribonucleic acids in extrapituitary tissues: intronless transcripts in testes and long poly(A) tails in hypothalamus. Mol. Endocrinol. 1 (1987) 749-757
14. Kalies K.U., and Hartmann E. Protein translocation into the endoplasmic reticulum (ER)-two similar routes with different modes. Eur. J. Biochem. 254 (1998) 1-5
15. Katahira M., Iwasaki Y., Aoki Y., Oiso Y., and Saito H. Cytokine regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. Endocrinology 139 (1998) 2414-2422
16. Lacaze-Masmonteil T., de Keyzer Y., Luton J.P., Kahn A., and Bertagna X. Characterization of proopiomelanocortin transcripts in human nonpituitary tissues. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 7261-7265
17. Lansac G., Dong W., Dubois C.M., Benlarbi N., Afonso C., Fournier I., Salzet M., and Day R. Lipopolysaccharide mediated regulation of neuroendocrine associated proprotein convertases and neuropeptide precursor processing in the rat spleen. J. Neuroimmunol. 171 (2006) 57-71
18. Lyons P.D., and Blalock J.E. Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytes. J. Neuroimmunol. 78 (1997) 47-56
19. Machelska H., Schopohl J.K., Mousa S.A., Labuz D., Schafer M., and Stein C. Different mechanisms of intrinsic pain inhibition in early and late inflammation. J. Neuroimmunol. 141 (2003) 30-39
20. Max N., Wolf K., Thiel E., and Keilholz U. Quantitative nested real-time RT-PCR specific for tyrosinase transcripts to quantitate minimal residual disease. Clin. Chim. Acta 317 (2002) 39-46
21. Mousa S.A., Machelska H., Schafer M., and Stein C. Co-expression of beta-endorphin with adhesion molecules in a model of inflammatory pain. J. Neuroimmunol. 108 (2000) 160-170
22. Mousa S.A., Zhang Q., Sitte N., Ji R., and Stein C. beta-Endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue. J. Neuroimmunol. 115 (2001) 71-78
23. Mousa S.A., Shakibaei M., Sitte N., Schafer M., and Stein C. Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain. Endocrinology 145 (2004) 1331-1341
24. Oates E.L., Allaway G.P., Armstrong G.R., Boyajian R.A., Kehrl J.H., and Prabhakar B.S. Human lymphocytes produce pro-opiomelanocortin gene-related transcripts. Effects of lymphotropic viruses. J. Biol. Chem. 263 (1988) 10041-10044
25. Przewlocki R., Hassan A.H., Lason W., Epplen C., Herz A., and Stein C. Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception. Neuroscience 48 (1992) 491-500
26. Raffin-Sanson M.L., Massias J.F., Ankotche A., Coste J., de Keyzer Y., Oliver C., Dumont C., Cabrol D., Ferre F., and Bertagna X. High precursor level in maternal blood results from the alternate mode of proopiomelanocortin processing in human placenta. Clin. Endocrinol. (Oxf.) 50 (1999) 85-94
27. Rees D.A., Hepburn P.J., McNicol A.M., Francis K., Jasani B., Lewis M.D., Farrell W.E., Lewis B.M., Scanlon M.F., and Ham J. Loss of ACTH expression in cultured human corticotroph macroadenoma cells is consistent with loss of the POMC gene signal sequence. Mol. Cell. Endocrinol. 189 (2002) 51-57
28. Rittner H.L., Brack A., Machelska H., Mousa S.A., Bauer M., Schafer M., and Stein C. Opioid peptide-expressing leukocytes: identification, recruitment, and simultaneously increasing inhibition of inflammatory pain. Anesthesiology 95 (2001) 500-508
29. Rittner H.L., Labuz D., Schaefer M., Mousa S.A., Schulz S., Schäfer M., Stein C., and Brack A. Pain control by CXCR2 ligands through Ca2+-regulated release of opioids from polymorphonuclear cells. FASEB J. 20 (2006) 2627-2629
30. Rubinstein M., Japon M.A., and Low M.J. Introduction of a point mutation into the mouse genome by homologous recombination in embryonic stem cells using a replacement type vector with a selectable marker. Nucleic Acids Res. 21 (1993) 2613-2617
31. Rubinstein M., Mogil J.S., Japon M., Chan E.C., Allen R.G., and Low M.J. Absence of opioid stress-induced analgesia in mice lacking beta-endorphin by site-directed mutagenesis. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 3995-4000
32. Schäfer M., Carter L., and Stein C. Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 4219-4223
33. Schäfer M., Mousa S.A., Zhang Q., Carter L., and Stein C. Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 6096-6100
34. Schäfer M., Mousa S.A., and Stein C. Corticotropin-releasing factor in antinociception and inflammation. Eur. J. Pharmacol. 323 (1997) 1-10
35. Scholzen, T.E., Kalden, D.H., Brzoska, T., Fisbeck, T., Fastrich, M., Schiller, M., Bohm, M., Schwarz, T., Armstrong, C.A., Ansel, J.C., Luger, T.A., 2000. Expression of proopiomelanocortin peptides in human dermal microvascular endothelial cells: evidence for a regulation by ultraviolet light and interleukin-1. J. Invest. Dermatol. 115, 1021-1028.
36. Sharp B., and Linner K. What do we know about the expression of proopiomelanocortin transcripts and related peptides in lymphoid tissue?. Endocrinology 133 (1993) 1921A-1921B
37. Slominski A., Wortsman J., Luger T., Paus R., and Solomon S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol. Rev. 80 (2000) 979-1020
38. Stein C., Gramsch C., and Herz A. Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and beta-endorphin. J. Neurosci. 10 (1990) 1292-1298
39. Stein C., Hassan A.H., Przewlocki R., Gramsch C., Peter K., and Herz A. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 5935-5939
40. Stein C., Hassan A.H., Lehrberger K., Giefing J., and Yassouridis A. Local analgesic effect of endogenous opioid peptides. Lancet 342 (1993) 321-324
41. Stein C., Schafer M., and Machelska H. Attacking pain at its source: new perspectives on opioids. Nat. Med. 9 (2003) 1003-1008
42. Stephanou A., Fitzharris P., Knight R.A., and Lightman S.L. Characteristics and kinetics of proopiomelanocortin mRNA expression by human leucocytes. Brain Behav. Immun. 5 (1991) 319-327
43. Tak P.P., Smeets T.J., Daha M.R., Kluin P.M., Meijers K.A., Brand R., Meinders A.E., and Breedveld F.C. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum. 40 (1997) 1912-1914
44. van Woudenberg A.D., Metzelaar M.J., van der Kleij A.A., de Wied D., Burbach J.P., and Wiegant V.M. Analysis of proopiomelanocortin (POMC) messenger ribonucleic acid and POMC-derived peptides in human peripheral blood mononuclear cells: no evidence for a lymphocyte-derived POMC system. Endocrinology 133 (1993) 1922-1933
45. Verma-Gandhu M., Bercik P., Motomura Y., Verdu E.F., Khan W.I., Blennerhassett P.A., Wang L., El-Sharkawy R.T., and Collins S.M. CD4(+) T-cell modulation of visceral nociception in mice. Gastroenterology 130 (2006) 1721-1728
46. Verma-Gandhu, M., Verdu, E.F., Cohen-Lyons, D.P., Collins, S.M., in press. Lymphocyte mediated regulation of {beta}-endorphin in the myenteric plexus. Am. J. Physiol. Gasterointest. Liver Physiol. (Sep 7, Epub ahead of print).
47. Wei L.-N., Hu X., Bi J., and Loh H. Post-transcriptional regulation of mouse k-opioid receptor expression. Mol. Pharmacol. 57 (2000) 401-408
48. Westly H.J., Kleiss A.J., Kelley K.W., Wong P.K., and Yuen P.H. Newcastle disease virus-infected splenocytes express the proopiomelanocortin gene. J. Exp. Med. 163 (1986) 1589-1594
49. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110